Skip to content

Clinical trial of efficacy and safety of magnetic traction field exposure system

Clinical trial of efficacy and safety of magnetic traction field exposure system

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089598
Enrollment
Unknown
Registered
2024-09-11
Start date
2023-12-04
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary nodule

Interventions

control group:Traditional thoracoscopic cuneiform pulmonary resection
Experimental group:Thoracoscopic cuneiform pulmonary resection assisted by magnetic traction field exposure system

Sponsors

The First Affiliated Hospital of Xi 'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: All of the following criteria must be met to be eligible: 1. Subjects aged 18-75 years old, gender unlimited; 2. Subject plans to undergo thoracoscopic surgery: 3. The subjects or their guardians can understand the purpose of the experiment, are willing to cooperate with treatment and follow-up, voluntarily participate in the experiment and sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Subjects with cardiac pacemakers, nerve stimulators, artificial metal heart valves, etc.; 2. Subjects with aneurysm clips, except titanium alloy; 3. The subjects have implanted hearing AIDS or ferromagnetic prostheses; 4. Subjects with obvious comorbidities, such as cardiovascular disease, neuromuscular disease, chronic obstructive pulmonary disease and urinary system disease (renal failure), which cannot be performed endoscopic surgery; 5. The subject has abnormal coagulation function; 6. The subject is pregnant or plans to become pregnant during study participation; 7. The subject has participated in other device, drug or biological research within 1 month; The researchers found it unfit to participate in the trial.

Design outcomes

Primary

MeasureTime frame
The rate of good surgical field exposure;

Secondary

MeasureTime frame
Functional evaluation;Stability evaluation;Incidence of adverse events;

Countries

China

Contacts

Public ContactYong Zhang

The First Affiliated Hospital of Xi 'an Jiaotong University

zhangyongyang05@163.com+86 189 9123 2612

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026